Ver mas grande
TAF9 antibody
FT-FNab08489
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IP |
| Target | TAF9 |
| Research Area | Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | TAF9 RNA polymerase II, TATA box binding protein(TBP)-associated factor, 32kDa |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Transcription initiation factor TFIID subunit 9|RNA polymerase II TBP-associated factor subunit G|STAF31/32|Transcription initiation factor TFIID 31 kDa subunit (TAFII-31, TAFII31)|Transcription initiation factor TFIID 32 kDa subunit (TAFII-32, TAFII32)|T |
| Host | Rabbit |
| UniProt ID | Q16594 |
| Gene ID | 6880 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 24-28 kDa |
| Background | Essential for cell viability. TAF9 and TAF9B are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. May have a role in gene regulation associated with apoptosis. TAFs are components of the transcription |
Más información
TAF9 antibody